Single arm
Single arm is an intervention with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders
Clinical Trials (6)
Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders
Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes
All 6 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 6